title: Variability in the efficacy of the IL1 receptor antagonist anakinra for treating Erdheim-Chester disease.
authors: Service de Médecine Interne 2, Centre National de Référence Maladies Auto-immunes Systémiques Rares, Institut E3M, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Université Pierre et Marie Curie, Université Paris VI, Paris, France; and.
authors: Fleur
authors: F
authors: Cohen-Aubart
authors: Université Pierre et Marie Curie, Université Paris VI, Paris, France; and Service de Médecine Nucléaire.
authors: Philippe
authors: P
authors: Maksud
authors: Université Pierre et Marie Curie, Université Paris VI, Paris, France; and Service de Médecine Interne 1.
authors: David
authors: D
authors: Saadoun
authors: Service de Neuroradiologie Diagnostique et Fonctionnelle.
authors: Aurélie
authors: A
authors: Drier
authors: Université Pierre et Marie Curie, Université Paris VI, Paris, France; and Service d'Anatomo-Pathologie, and.
authors: Frédéric
authors: F
authors: Charlotte
authors: Service de Radiologie, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.
authors: Philippe
authors: P
authors: Cluzel
authors: Service de Médecine Interne 2, Centre National de Référence Maladies Auto-immunes Systémiques Rares, Institut E3M, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Université Pierre et Marie Curie, Université Paris VI, Paris, France; and.
authors: Zahir
authors: Z
authors: Amoura
authors: Service de Médecine Interne 2, Centre National de Référence Maladies Auto-immunes Systémiques Rares, Institut E3M, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Université Pierre et Marie Curie, Université Paris VI, Paris, France; and.
authors: Julien
authors: J
authors: Haroche
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001842:Bone and Bones / Q000000981:diagnostic imaging / Q000473:pathology; D002097:C-Reactive Protein / Q000032:analysis; D002490:Central Nervous System / Q000000981:diagnostic imaging / Q000473:pathology; D018450:Disease Progression; D004351:Drug Resistance; D031249:Erdheim-Chester Disease / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D005221:Fatigue / Q000139:chemically induced; D005260:Female; D006321:Heart / Q000000981:diagnostic imaging; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D053590:Interleukin 1 Receptor Antagonist Protein / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000473:pathology; D009928:Organ Specificity; D010146:Pain / Q000139:chemically induced; D049268:Positron-Emission Tomography; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D016898:Interferon-alpha; D053590:Interleukin 1 Receptor Antagonist Protein; D002097:C-Reactive Protein